Premium
Venetoclax with azacitidine for two younger Jehovahʼs Witness patients with high risk acute myeloid leukemia
Author(s) -
Bock Allison M.,
Pollyea Daniel A.
Publication year - 2020
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25916
Subject(s) - venetoclax , azacitidine , myeloid leukemia , medicine , myeloid , leukemia , oncology , chronic lymphocytic leukemia , biology , genetics , gene expression , dna methylation , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom